The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials

After extended weakness, biotech stocks turned a corner along with the broader markets to close out the week. With just a session left, it looks less likely the sector ends in the black for the year.

The following are catalysts that could dictate the moves of biotech stocks in the unfolding week.